Advertisement

Topics

Lilly Corporate Center Company Profile

21:00 EDT 24th September 2018 | BioPortfolio

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve <!--LGfEGNT2Lhm-->healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME’s principal focus has been on applying its proprietary AMEsystem™ technology platform to the full range of <!--LGfEGNT2Lhm-->protein therapeutic candidates including antibodies, cytokines, hormones and enzymes to develop novel human biotherapeutic candidates.
Since February 2004, AME has been a wholly-owned subsidiary of <!--LGfEGNT2Lhm-->Eli Lilly and Company and is an integral part of Lilly’s research organization. Lilly, a leading innovation-driven corporation is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Lilly provides answers – through medicines and information – for some of the world’s most urgent medical needs.

While geographically separate, AME works closely with Lilly colleagues in Indianapolis and around the world, sharing a corporate legacy of integrity and commitment to quality that spans more than a century.

 

Lilly(TM) is a registered trademark of Eli Lilly and Company.  BioPortfolio's use of the Lilly(TM) trademark on this site does not imply any affiliation with or endorsement by Eli Lilly and Company.  If you are looking for Eli Lilly and Company's official website, please visit www.lilly.com.

Location

Mail Drop Code 1854
Indianapolis
Indiana
46285
United States of America

Contact

Phone: 317-276-2790
Fax: 317-276-4878


News Articles [1320 Associated News Articles listed on BioPortfolio]

Lilly Diabetes Center of Excellence Established

Eli Lilly and the Indiana Bioscience Research Institute (IBRI) have partnered with Indiana University (IU) School of Medicine to create the Lilly Diabetes Center of Excellence (LDCE), with the goal of...

Eli Lilly forms Chinese alliance for diabetes care

Eli Lilly has partnered with the National Center for Cardiovascular Diseases (NCCD) in China to promote scientific understanding and care...Read More... The post Eli Lilly forms Chinese alliance for d...

Lilly To Acquire AurKa Pharma

NewsThe acquisition expands Lilly oncology pipeline with early-phase asset being studied in multiple tumor types.

Overseas Partnerships: Eli Lilly Forges Chinese Diabetes Collaboration

China continues to be a hotbed of investment for U.S. pharmaceutical and biotech companies. Last week BioSpace reported that China expects to see exponential industry growth by 2022 and today Eli Lill...

Lilly Reacquires Aurora Kinase Inhibitor Via AurKa Buy For $110m

Many Aurora kinase inhibitors have entered development, but while none have had a successful end, Lilly believes the specificity of...   

M&As this week: Eli Lilly, Fujifilm Holdings, Canopy Growth

US-based healthcare company Eli Lilly and Company has agreed to acquire AurKa Pharma Inc. Eli Lilly will purchase all shares of...Read More... The post M&As this week: Eli Lilly, Fujifilm Holding...

Eli Lilly: The Issues With Drug Development and Regaining the Public's Trust

In this episode of PharmaTelevision News Review, Paul Larsmon talks with Gino Santini, Vice President, Corporate Strategy, at Eli Lilly. Filmed at BIO-Europe 2009, they discuss: • Eli Lilly's CEO's ...

Versicor Licenses Fungicidal Agent from Eli Lilly and Co.

Versicor Inc. (Fremont, CA) and Eli Lilly and Co. (Indianapolis) have entered into licensing agreement under which Versicor will receive exclusive worldwide rights to LY303366, Lilly's semi-synthetic ...

Drugs and Medications [33 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [Indiana Oxygen Company, Inc.]

Xigris [Eli Lilly and Company]

These highlights do not include all the information needed to use XIGRIS safely and effectively. See full prescribing information for XIGRIS.XIGRIS (drotrecogin alfa (activated)) injection, powder, ly...

Axid ar [Wyeth Consumer Healthcare]

Axid AR (nizatidine)

Humulin [Eli Lilly and Company]

HUMULIN 70/3070% HUMAN INSULIN ISOPHANE SUSPENSION AND 30% HUMAN INSULIN INJECTION (rDNA ORIGIN)100 UNITS PER ML (U-100)

Gemzar [Eli Lilly and Company ]

These highlights do not include all the information needed to use GEMZAR safely and effectively. See full prescribing information for GEMZAR.GEMZAR (gemcitabine for injection) Powder, Lyophilized, For...

PubMed Articles [547 Associated PubMed Articles listed on BioPortfolio]

The Acetabular Fossa May Not Be Located at the True Center of the Acetabulum: A Detailed Analysis Using Preoperative CT Images.

The acetabular fossa is thought to be located in the center of the acetabulum, and acetabular reaming in total hip arthroplasty is conventionally performed in the center of the fossa. However, the act...

Head and Neck Cancer in World Trade Center Responders: A Case Series.

To report on cases of head and neck cancer (HNC) among World Trade Center (WTC) responders participating in the WTC Health Program and seen at Rutgers WTC Center of Clinical Excellence.

Real-time Imaging Revealed Exoelectrogens from Wastewater Are Selected at the Center of Gradient Electric Field.

Exoelectrogens acclimated from the environment are the key of energy recovery from waste in bioelectrochemical systems. However, it is still unknown how these bacteria were selectively enriched on the...

The Barrow Innovation Center Case Series: A novel 3D-printed retractor for use with electromagnetic neuronavigation systems.

The Barrow Innovation Center consists of an educational program that promotes interdisciplinary collaboration among neurosurgery, legal, and engineering professionals to foster the development of new ...

Walking balance on a treadmill changes during pregnancy.

Altered standing balance during pregnancy has been previously reported. To date, body center of mass (bCOM) motion has not been used to track balance changes in this population. We recently compared t...

Clinical Trials [1711 Associated Clinical Trials listed on BioPortfolio]

G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

This is a non-inferiority, multi-center, randomized, controlled, single-blind, two-way crossover efficacy and safety study in subjects with Type 1 diabetes mellitus. The study involves two...

Safety and Efficacy of G-Pen™ (Glucagon Injection) Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics

This is a blinded, randomized crossover study to compare the safety and efficacy of G-Pen™ (glucagon injection) to Lilly Glucagon (glucagon for injection [rDNA origin]) for hypoglycemia ...

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients

This study aims to assess the effects of early basal insulin therapy in previously non-diabetic de novo kidney transplant patients in reducing the incidence of new onset diabetes in partic...

Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France

The treating physician/investigator contacts Lilly when, based on their medical opinion, a patient meets the criteria for inclusion in the ATU.

Lilly's Emotional and Physical Symptoms of Depression

To assess the effectiveness of duloxetine administered once daily in patients with Major Depressive Disorder in a practice based setting

Companies [1529 Associated Companies listed on BioPortfolio]

Eli Lilly and Company

<!--LGfEGNT2Lhm-->Eli Lilly and Company is a leading, innovation-driven corporation committed to developing a growing portfolio of best-in-class and first-in-class pharmaceutical products that...

Lilly USA

Eli Lilly and Company, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and fro...

Lilly Corporate Center

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve <!--LGfEGNT2Lhm-->healthcare by discovering, optimizing and developing human biotherapeutics. ...

Corporate Action Network

Corporate Action Network was founded to address the imbalance of power between corporations and people. Using the new tools of the Action Network and a networked approach, Corpora...

Applied Molecular Evolution

Applied Molecular Evolution (AME) is a leader in applying directed molecular evolution to improve healthcare by discovering, optimizing and developing human biotherapeutics. Since its inception, AME...

More Information about "Lilly Corporate Center" on BioPortfolio

We have published hundreds of Lilly Corporate Center news stories on BioPortfolio along with dozens of Lilly Corporate Center Clinical Trials and PubMed Articles about Lilly Corporate Center for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lilly Corporate Center Companies in our database. You can also find out about relevant Lilly Corporate Center Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Corporate Database Quicklinks



Searches Linking to this Company Record